Workers inside facility in hazmat suits, working at batch machine.

Mark Cuban Cost Plus Drug Company

Mark Cuban Cost Plus Drug Company | Dallas, TX

Mark Cuban Cost Plus Drug Company’s Sterile Fill Finish Facility is a DPR Construction project in the Deep Ellum area of Dallas. The project consists of conversion and upgrade of a 22,600-sq.-ft. office/warehouse space to develop into a fill/finish space for small-batch generic prescription medication, the first-of-its-kind for the company.

The facility will serve as a pilot plant for future commercial manufacturing sites that will focus on producing generic prescription drugs that are currently on the FDA shortage list, ones that would normally not, but now become accessible for all, regardless of insurance status.

Fill/finish facility interior shot.
Photo by Kevin Brown
Fill/finish machine shot with door open and screen.
Photo by Kevin Brown

Mark Cuban Cost Plus Drug Company Finish/Fill Facility is one of the first Life Science projects in the Deep Ellum area of Dallas, TX.

The project is a conversion and upgrade of a 22,600-sq.-ft. office/warehouse space to make it into a fill/finish space for small batch vaccines and other prescription medication.

Fill/finish facility interior shot.
Photo by Kevin Brown

Mark Cuban Cost Plus Drug Company Finish/Fill Facility is one of the first Life Science projects in the Deep Ellum area of Dallas, TX.

Fill/finish machine shot with door open and screen.
Photo by Kevin Brown

The project is a conversion and upgrade of a 22,600-sq.-ft. office/warehouse space to make it into a fill/finish space for small batch vaccines and other prescription medication.

Craft Workers standing on job site under ceremonial steel beam.
Photo by Tyler Holleman
Ceremonial steel beam containing tree, American flag and Texas flag is lifted in the sky
Photo by Tyler Holleman
Man speaks on microphone in front of seated Craft workers
Photo by Tyler Holleman
People stand in front of project site shoulder to shoulder facing camera
Photo by Tyler Holleman
Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The project team watches as the ceremonial steel beam is placed during the Topping Out Celebration.

Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The ceremonial steel beam signed by the entire team and all attendees is hoisted in the air while everyone watches.

Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

MCCPDC Founder and CEO Dr. Alex Oshmyansky thanks the project team during the celebratory lunch at the project site.

Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The DPR Construction project team poses by the ceremonial steel beam signed by all attendees before it is hoisted into place.

Craft Workers standing on job site under ceremonial steel beam.
Photo by Tyler Holleman
Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The project team watches as the ceremonial steel beam is placed during the Topping Out Celebration.

Ceremonial steel beam containing tree, American flag and Texas flag is lifted in the sky
Photo by Tyler Holleman
Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The ceremonial steel beam signed by the entire team and all attendees is hoisted in the air while everyone watches.

Man speaks on microphone in front of seated Craft workers
Photo by Tyler Holleman
Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

MCCPDC Founder and CEO Dr. Alex Oshmyansky thanks the project team during the celebratory lunch at the project site.

People stand in front of project site shoulder to shoulder facing camera
Photo by Tyler Holleman
Life Sciences Icon

Mark Cuban Cost Plus Drug Company Team Celebrates Topping Out Milestone

The DPR Construction project team poses by the ceremonial steel beam signed by all attendees before it is hoisted into place.

We think you'll like this, too.